Mechanism and Countermeasure of Fentanyl-Induced Sudden Death
Funded at Lovelace Biomedical Research Institute · NIH-11237080 · Data updated 2026-11-12
A patient-facing overview of how fentanyl can cause sudden breathing failure and what researchers are testing to prevent these deaths.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lovelace Biomedical Research Institute NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project start | January 1, 2023 |
| Project end | November 30, 2026 |
| Funding year | 2026 |
| Award (this year) | $898,339 |
| NIH project number | 5R01HL163512-04 |
| Project ID | NIH-11237080 on NIH RePORTER |
Who could benefit from this research
✓Could help
People at risk of fentanyl overdose or those with a history of opioid use disorder may benefit from future therapies developed from this work.
✕Less likely to help
Healthy individuals without exposure risk are unlikely to benefit directly from these findings.
What this research studies
This grant focuses on understanding why fentanyl can cause rapid breathing problems and sudden death, and it tests potential ways to counteract these effects. Researchers will study how airway nerves respond to fentanyl and whether targeted treatments can stop dangerous breathing loss. The work includes experiments to identify mechanisms and test countermeasures that could protect people who misuse fentanyl or are at risk of overdose. The goal is to develop safer, effective strategies to prevent fatal apnea in overdose situations.
Why it matters
Potential benefit: If successful, the research could lead to new interventions that prevent fentanyl-related sudden death.
How similar studies have gone: Prior research has begun to uncover the neural pathways involved in opioid-induced breathing problems, with some promising leads toward countermeasures.
Where this research is happening
-
Lovelace Biomedical Research Institute
Albuquerque, United States Active
Researchers
- Principal investigator: Xu, Fadi — Lovelace Biomedical Research Institute
- Study coordinator: Xu, Fadi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.